Correction: Bacopaside I ameliorates cognitive impairment in APP/PS1 mice via immune-mediated clearance of β-amyloid, (Original article: Aging (Albany NY) 2016; 8(3), (521–533), (PMID: 26946062), (PMCID: PMC4833143), (10.18632/aging.100913));Bacopaside I ameliorates cognitive impairment in APP/PS1 mice via immune-mediated clearance of β-amyloid

Aging

Volumn 8, Issue 3, 2016, Pages 521-533

  Li, Yuanyuan ^a   Yuan, Xing ^a   Shen, Yunheng ^a   Zhao, Jing ^b   Yue, Rongcai ^a   Liu, Fang ^a   He, Weiwei ^c   Wang, Rui ^c   Shan, Lei ^a   Zhang, Weidong ^a,d  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b Logistical Engineering University of PLA   (China)

^c EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^d SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY   (China)

Author keywords

Alzheimer's disease; APP PS1mice; Bacopaside I; Immune; Phagocytosis; amyloid; Alzheimer s disease; immune; phagocytosis

Indexed keywords

AMYLOID BETA PROTEIN; BACOPASIDE I; PROTEOME; SAPONIN; TRITERPENE;

ALZHEIMER DISEASE; ANIMAL; BACOPA; C57BL MOUSE; DISEASE MODEL; DRUG EFFECTS; IMMUNOLOGY; MALE; MEMORY; METABOLISM; PHYTOTHERAPY; TRANSGENIC MOUSE; WESTERN BLOTTING;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BACOPA; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; MALE; MEMORY; MICE, INBRED C57BL; MICE, TRANSGENIC; PHYTOTHERAPY; PROTEOME; SAPONINS; TRITERPENES;

EID: 85019246098     PISSN: None     EISSN: 19454589     Source Type: Journal    
DOI: 10.18632/AGING.204531     Document Type: Erratum

References (43)

1. Zhang XH, Chen SY, Tang L, Shen YZ, Luo L, Xu CW, Liu Q and Li D. Myricetin Induces Apoptosis in Hepg2 Cells through Akt/P70s6k/Bad Signaling and Mitochondrial Apoptotic Pathway. Anticancer Agents Med Chem. 2013; 10:1575-1581
2. Hardy J and Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 2002; 297:353-356
3. Town T. Alternative Abeta immunotherapy approaches for Alzheimer's disease. CNS Neurol Disord Drug Targets. 2009; 8:114-127
4. Lemere CA. Developing novel immunogens for a safe and effective Alzheimer's disease vaccine. Prog Brain Res. 2009; 175:83-93
5. Lukiw WJ. Emerging amyloid beta (Ab) peptide modulators for the treatment of Alzheimer's disease (AD). Expert Opin Emerg Drugs. 2008; 13:255-271
6. Check E. Nerve inflammation halts trial for Alzheimer's drug. Nature. 2002; 415:462
7. Wisniewski T and Frangione B. Immunological and antichaperone therapeutic approaches for Alzheimer disease. Brain Pathol. 2005; 15:72-77
8. Essa MM, Vijayan RK, Castellano-Gonzalez G, Memon MA, Braidy N and Guillemin GJ. Neuroprotective effect of natural products against Alzheimer's disease. Neurochem Res. 2012; 37:1829-1842
9. Albarracin SL, Stab B, Casas Z, Sutachan JJ, Samudio I, Gonzalez J, Gonzalo L, Capani F, Morales L and Barreto GE. Effects of natural antioxidants in neurodegenerative disease. Nutr Neurosci. 2012; 15:1-9
10. Kongkeaw C, Dilokthornsakul P, Thanarangsarit P, Limpeanchob N and Norman Scholfield C. Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract. J Ethnopharmacol. 2014; 151:528-535
11. Neale C, Camfield D, Reay J, Stough C and Scholey A. Cognitive effects of two nutraceuticals Ginseng and Bacopa benchmarked against modafinil: a review and comparison of effect sizes. Br J Clin Pharmacol. 2013; 75:728-737
12. Das A, Shanker G, Nath C, Pal R, Singh S and Singh H. A comparative study in rodents of standardized extracts of Bacopa monniera and Ginkgo biloba: anticholinesterase and cognitive enhancing activities. Pharmacol Biochem Behav. 2002; 73:893-900
13. Russo A, Borrelli F, Campisi A, Acquaviva R, Raciti G and Vanella A. Nitric oxide-related toxicity in cultured astrocytes: effect of Bacopa monniera. Life Sci. 2003; 73:1517-1526
14. Sairam K, Dorababu M, Goel RK and Bhattacharya SK. Antidepressant activity of standardized extract of Bacopa monniera in experimental models of depression in rats. Phytomedicine. 2002; 9:207-211
15. Liu X, Liu F, Yue R, Li Y, Zhang J, Wang S, Zhang S, Wang R, Shan L and Zhang W. The antidepressant-like effect of bacopaside I: Possible involvement of the oxidative stress system and the noradrenergic system. Pharmacol Biochem Behav. 2013; 110:224-230
16. Liu X, Yue R, Zhang J, Shan L, Wang R and Zhang W. Neuroprotective effects of bacopaside I in ischemic brain injury. Restor Neurol Neurosci. 2013; 31:109-123
17. Dutescu RM, Li QX, Crowston J, Masters CL, Baird PN and Culvenor JG. Amyloid precursor protein processing and retinal pathology in mouse models of Alzheimer's disease. Graefes Arch Clin Exp Ophthalmol. 2009; 247:1213-1221
18. Kumar V. Potential medicinal plants for CNS disorders: an overview. Phytother Res. 2006; 20:1023-1035
19. Janus C, Phinney AL, Chishti MA and Westaway D. New developments in animal models of Alzheimer's disease. Curr Neurol Neurosci Rep. 2001; 1:451-457
20. Araujo DM and Cotman CW. Beta-amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease. Brain Res. 1992; 569:141-145
21. Dong H, Yuede CM, Coughlan C, Lewis B and Csernansky JG. Effects of memantine on neuronal structure and conditioned fear in the Tg2576 mouse model of Alzheimer's disease. Neuropsychopharmacology. 2008; 33:3226-3236
22. Durairajan SS, Liu LF, Lu JH, Chen LL, Yuan Q, Chung SK, Huang L, Li XS, Huang JD and Li M. Berberine ameliorates betaamyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model. Neurobiol Aging. 2012; 33:2903-2919
23. Harikumar KB and Aggarwal BB. Resveratrol: a multitargeted agent for age-associated chronic diseases. Cell Cycle. 2008; 7:1020-1035
24. Bettens K, Sleegers K and Van Broeckhoven C. Genetic insights in Alzheimer's disease. Lancet Neurol. 2013; 12:92-104
25. Wyss-Coray T. Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat Med. 2006; 12:1005-1015
26. Yong VW and Rivest S. Taking advantage of the systemic immune system to cure brain diseases. Neuron. 2009; 64:55-60
27. Chakrabarty P, Herring A, Ceballos-Diaz C, Das P and Golde TE. Hippocampal expression of murine TNFalpha results in attenuation of amyloid deposition in vivo. Mol Neurodegener. 2011; 6:16
28. Chakrabarty P, Ceballos-Diaz C, Beccard A, Janus C, Dickson D, Golde TE and Das P. IFN-gamma promotes complement expression and attenuates amyloid plaque deposition in amyloid beta precursor protein transgenic mice. J Immunol. 2010; 184:5333-5343
29. Shaftel SS, Kyrkanides S, Olschowka JA, Miller JN, Johnson RE and O'Banion MK. Sustained hippocampal IL-1 beta overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology. J Clin Invest. 2007; 117:1595-1604
30. Byeon SE, Choi WS, Hong EK, Lee J, Rhee MH, Park HJ and Cho JY. Inhibitory effect of saponin fraction from Codonopsis lanceolata on immune cell-mediated inflammatory responses. Arch Pharm Res. 2009; 32:813-822
31. Nixon RA. Autophagy, amyloidogenesis and Alzheimer disease. J Cell Sci. 2007; 120:4081-4091
32. Koenigsknecht-Talboo J and Landreth GE. Microglial phagocytosis induced by fibrillar beta-amyloid and IgGs are differentially regulated by proinflammatory cytokines. J Neurosci. 2005; 25:8240-8249
33. Tohda C, Urano T, Umezaki M, Nemere I and Kuboyama T. Diosgenin is an exogenous activator of 1, 25D(3)-MARRS/Pdia3/ERp57 and improves Alzheimer's disease pathologies in 5XFAD mice. Sci Rep. 2012; 2:535
34. Zhu Z, Yan J, Jiang W, Yao XG, Chen J, Chen L, Li C, Hu L, Jiang H and Shen X. Arctigenin effectively ameliorates memory impairment in Alzheimer's disease model mice targeting both beta-amyloid production and clearance. J Neurosci. 2013; 33:13138-13149
35. Li Y, Gu JF, Zou X, Wu J, Zhang MH, Jiang J, Qin D, Zhou JY, Liu BX, Zhu YT, Jia XB, Feng L and Wang RP. The anti-lung cancer activities of steroidal saponins of P. polyphylla Smith var. chinensis (Franch.) Hara through enhanced immunostimulation in experimental Lewis tumor-bearing C57BL/6 mice and induction of apoptosis in the A549 cell line. Molecules. 2013; 18:12916-12936
36. Monterrosas-Brisson N, Ocampo ML, Jimenez-Ferrer E, Jimenez-Aparicio AR, Zamilpa A, Gonzalez-Cortazar M, Tortoriello J and Herrera-Ruiz M. Anti-inflammatory activity of different agave plants and the compound cantalasaponin-1. Molecules. 2013; 18:8136-8146
37. Chakravarty AK, Sarkar T, Masuda K, Shiojima K, Nakane T and Kawahara N. Bacopaside I and II: two pseudojujubogenin glycosides from Bacopa monniera. Phytochemistry. 2001; 58:553-556
38. Zhou Y, Shen YH, Zhang C, Su J, Liu RH and Zhang WD. Triterpene saponins from Bacopa monnieri and their antidepressant effects in two mice models. J Nat Prod. 2007; 70:652-655
39. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods. 1984; 11:47-60
40. Zhu Z, Li C, Wang X, Yang Z, Chen J, Hu L, Jiang H and Shen X. 2, 2', 4'-trihydroxychalcone from Glycyrrhiza glabra as a new specific BACE1 inhibitor efficiently ameliorates memory impairment in mice. J Neurochem. 2010; 114:374-385
41. Mahon P and Dupree P. Quantitative and reproducible twodimensional gel analysis using Phoretix 2D Full. Electrophoresis. 2001; 22:2075-2085
42. Yuan X, Yan S, Zhao J, Shi D, Yuan B, Dai W, Jiao B, Zhang W and Miao M. Lipid metabolism and peroxisome proliferatoractivated receptor signaling pathways participate in late-phase liver regeneration. J Proteome Res. 2011; 10:1179-1190
43. Kren BT, Trembley JH, Krajewski S, Behrens TW, Reed JC and Steer CJ. Modulation of apoptosis-associated genes bcl-2, bcl-x, and bax during rat liver regeneration. Cell Growth Differ. 1996; 7:1633-1642